Dozens of successful projects in 10 countries, from pilots to full scale production
Finnish Student Health Service Finland
FSHS is responsible for the care of all 130.000 university students in Finland. FSHS uses Medixine Suite for all connected care, including annual triage of tens of thousands of students, video appointments, secure chats and messaging. The number of chat sessions average between 4000 to 5000 per month and due to the COVID-19 pandemic, the number of video sessions skyrocketed to 300-400 per day.
Linde is global medical gasses company having also an international home care business of over 1.5M patients. Linde chose Medixine as their solution for home monitoring and communication. First deployments are in Spain and Portugal.
Vitaflo (Nestlé) UK
A Nestlé UK subsidiary, Vitaflo concentrates on high end nutrition products. Their first Medixine-based service in the UK is now live and connects patients having ketogenic diets and their NHS dietitians.
Helsinki University Hospital (HUS) is currently piloting integration of Apple Health to their back end using Medixine. Medixine’s clinical remote monitoring solution is also in use in a hypertension research project.
UCB is a global biopharma company. UCB in Belgium is developing and piloting disease specific connected care services together with Medixine.
IEM is one of the pioneers in telehealth devices. IEM is now using Medixine as the back-end functionality for their telehealth devices, the solution will be distributed also by their over 50 international partners.
A-Clinic Ltd provides nationwide online therapy for people suffering addictions and mental health problems. Their unique online treatment program is based on Medixine Suite.
OmaTays is the patient portal for the Pirkanmaa region in Finland with a population of over 500.000. The Medixine Suite questionnaire module is one of the core features of the portal.
We are happy to tell you more!
Please fill in form below and we’ll get back to you as soon as possible. If you have something specific in mind, please tell us a bit about it in the message field.